IL6 and neoplasm: M1 macrophages typically express proinflammatory cytokines (e.g. IFN-β, IL-12, TNF, IL-6, and IL-1β) and MHC class II molecules, and carry a therapeutic benefit, promoting anti-tumor activities3.